×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [survival endpoints]
Home >
survival endpoints
Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent.
215 views
Lung Cancer Screening: Promise and Pitfalls Christine D. Berg, M.D. Chief, Early Detection Research Group Division of Cancer Prevention Christine D. Berg,
234 views